arrow
R

Roseline d'Oiron

université de rennes
H指数:33
被引数:3,806

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Life expectancy of people with hemophilia in France in 2022

2022年法国血友病患者预期寿命

2026-04-220
OAAI
Natural history of anti-platelet antibody formation in patients with Glanzmann thrombasthenia: A French multicenter prospective study

戈兰茨曼血栓basthenia患者抗血小板抗体形成自然史:一项法国多中心前瞻性研究

2026-04-210
PRE
Concizumab in hemophilia with inhibitors: Longer-term efficacy and safety results from the phase 3 explorer7 study

康加尼珠单抗在伴抑制物的血友病中的长期疗效和安全性结果:3期EXPLORER7研究

2026-01-120
OAAI
Unmet needs despite standard-of-care prophylaxis in hemophilia A: improved outcomes after switching to efanesoctocog alfa

尽管标准护理预防措施,血友病A中未满足的需求:转为使用efanesoctocog alfa后结局改善

2026-01-010
OA
Navigating the Transition From Adolescence to Adulthood Among Young People With Severe Haemophilia: The Qualitative Phase of the TRANSHEMO Project

严重血友病青年在从青春期过渡到成年期的导航:TRANSHEMO项目的定性研究阶段

2025-09-010
OAAI
F8 gene variants influence the response to desmopressin in hemophilia A carriers

F8基因变异影响血友病A携带者对去氨加压素的反应

Blood
IF23.1
2025-08-250
PRE
Contrasting Approaches in the Implementation of GRADE Methodology in Guidelines for Haemophilia and Von Willebrand Disease
2024-12-090
PRE
International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia-A Critical Appraisal
2024-12-060
PREAI
Type 2N von Willebrand disease: genotype drives different bleeding phenotypes and treatment needs
2024-10-011
PRE
Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A
2024-07-185
PRE
Quality of life of siblings of adolescents with severe haemophilia (FRATHEMO): An ancillary study to the TRANSHEMO project
2024-04-290
PRE